Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant drop in short interest in May. As of May 31st, there was short interest totalling 9,600 shares, a drop of 58.1% from the May 15th total of 22,900 shares. Based on an average trading volume of 707,400 shares, the days-to-cover ratio is […]
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 10,500 shares, a decline of 41.7% from the April 15th total of 18,000 shares. Based on an average daily trading volume, of 958,000 shares, […]
/PRNewswire/ Q BioMed, Inc. (OTCQB: QBIO) a commercial-stage biotechnology development company announces a new publication supporting the potential superior.
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 25,300 shares, a decrease of 48.9% from the May 15th total of 49,500 shares. Based on an average trading volume of 744,100 shares, the days-to-cover ratio is […]
Q BioMed (OTCMKTS:QBIO – Get Rating) and Indaptus Therapeutics (NASDAQ:INDP – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation. Profitability This table compares Q BioMed and Indaptus Therapeutics’ […]